Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
Sign Up to like & getrecommendations! Published in 2021 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202101202
Abstract: The therapeutic use of RNA interference is limited by the inability of siRNA molecules to reach their site of action, the cytosol of target cells. Lipid nanoparticles, including liposomes, are commonly employed as siRNA carrier… read more here.
Keywords: functional sirna; sirna delivery; delivery extracellular; delivery ... See more keywords